tradingkey.logo

SpyGlass poised to open higher in Nasdaq debut after $150 million IPO

ReutersFeb 6, 2026 4:00 PM

Biopharmaceutical company SpyGlass Pharma's SGP.O shares poised to open above offer price in Nasdaq debut

Stock indicated to open at $32 apiece vs $16 IPO price

SGP sold ~9.4 million shares within marketed range of $15 and $17 to raise $150 million

Founded in 2019 by Malik Kahook and Glenn Sussman, SGP is building a portfolio of drug delivery systems to provide long-acting therapy for chronic eye diseases

SGP's lead program, the BIM-IOL system, integrates glaucoma treatment into standard cataract surgery

Jefferies, Leerink Partners, Citigroup and Stifel were joint book-running managers for offering

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI